Decline depth
-30.1%
From rolling 252-day high of $36.82, 365d ago.
Past the 30% Amber threshold.
-30.1%
from rolling 252-day high of $36.82 set 2025-07-10 · 365d ago
Current
$25.75
Decline depth
-30.1%
Decline σ
1.1σ
TFC
3/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since tracking began
$ENOV has been tracked since 2026-03-01. It was down 36.8% from its 52-week high then — now down -30.1%.
It has clawed back 5.8 percentage points off that level. It bottomed 50.8% below that high along the way.
Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
ENOV qualifies for the Amber List on decline depth.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Past the 3/5 Watch threshold.
Decline sigma
1.1σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (5.81% per day).
The structural read
What price action says about ENOV.
ENOV qualifies for the Amber List on decline depth — down -30.1% from its rolling 252-day high.
Cross-confirmation: also showing 3/5 bearish time frames.
Earnings on file: 2026-05-07. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $20.55
32.0% of range
52W high $36.82
Sector context · Healthcare
132 other Healthcare tickers are on Broken Stocks.
62
Red List
33
Amber
37
Watch
-36.9%
Median decline
Worst in sector: UPB (-77.6%). Least-bad: ENTA (-20.1%). See all Healthcare listings →
Related — same sector
Closest decliners to ENOV
Amber List
RMD
ResMed Inc.
Amber ListRecovering
STVN
Stevanato Group S.p.A.
Amber List
SDGR
Schrodinger, Inc.
Amber List
ABT
Abbott Laboratories
Amber List
COLL
Collegium Pharmaceutical, Inc.
Amber List
GYRE
Gyre Therapeutics, Inc.
Questions about ENOV
What people ask.
Why is ENOV on Broken Stocks?
ENOV qualifies for the Amber List on decline depth. It is down -30.1% from its rolling 252-day high of $36.82, set on 2025-07-10 — 365d ago.
Is ENOV a falling knife?
Not by the strict technical definition. ENOV is down -30.1% from its 52-week high, but that high was set 365d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. ENOV is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.
Is ENOV a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is ENOV trading inside its 52-week range?
At $25.75, ENOV sits 32.0% of the way from its 52-week low ($20.55) to its 52-week high ($36.82). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has ENOV been declining?
The current 30.1% decline accrued over 365d, which annualizes to roughly -30.1% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does ENOV compare to its sector?
There are 132 other Healthcare tickers on Broken Stocks: 62 Red, 33 Amber, 37 Watch, with 46 showing recovering structural signals. Median sector decline is -36.9% — ENOV's decline is shallower than the sector median.
Does ENOV's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-07) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.